Abbott (NYSE: ABT) CEO sells 398K shares after option exercise
Rhea-AI Filing Summary
ABBOTT LABORATORIES (ABT) reported insider transactions by Chairman and CEO Robert B. Ford on 2026-08-25. He exercised employee stock options covering 398,832 common shares (151,869 at a $44.40 exercise price and 246,963 at $59.94), then sold a total of 398,832 common shares in open-market transactions at volume-weighted average prices in the $115–$116 range. In addition, 216,203 common shares are reported as held indirectly through the Ford Family Trust, where he serves as co-trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
Ford Robert B
Role
CHAIRMAN AND CEO
Sold
398,832 shs ($46.20M)
Approx. gross sale proceeds
$46.20M
Approx. exercise cost
$21.55M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (right to buy) F4 | 151,869 | $0.00 | $0.00 |
| Exercise | Option (right to buy) F5 | 246,963 | $0.00 | $0.00 |
| Exercise | Common shares without par value | 151,869 | $44.40 | $6.74M |
| Exercise | Common shares without par value | 246,963 | $59.94 | $14.80M |
| Sale | Common shares without par value F1 | 218,535 | $115.57 | $25.26M |
| Sale | Common shares without par value F2 | 180,297 | $116.19 | $20.95M |
| holding | Common shares without par value F3 | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 0 shares (Direct);
Common shares without par value — 306,461 shares (Direct);
Common shares without par value — 216,203 shares (Indirect, Ford Family Trust)
Footnotes (5)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $116.36, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3. Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.
- F4. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
- F5. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Key Figures
Options exercised: 398,832 shares
Option exercise price: $44.40 per share
Option exercise price: $59.94 per share
+5 more
8 metrics
Options exercised
398,832 shares
Total options exercised into common shares on 2026-08-25
Option exercise price
$44.40 per share
Exercise price for 151,869 options expiring 2027-02-16
Option exercise price
$59.94 per share
Exercise price for 246,963 options expiring 2028-02-15
Shares sold
218,535 shares
Open-market sale at $115.57 weighted average price on 2026-08-25
Shares sold
180,297 shares
Open-market sale at $116.19 weighted average price on 2026-08-25
Price range (first sale block)
$115.09–$116.08
Range of prices for 218,535 shares sold
Price range (second sale block)
$116.09–$116.36
Range of prices for 180,297 shares sold
Indirect trust holdings
216,203 shares
Common shares held by Ford Family Trust after transactions
Key Terms
weighted average price, Employee stock option, Incentive Stock Program, Rule 16b-3, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee stock option financial
"Employee stock option granted pursuant to the Abbott Laboratories 2009"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Incentive Stock Program financial
"granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program"
Rule 16b-3 regulatory
"in a transaction exempt from Section 16 under Rule 16b-3."
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
indirect financial
"Held in the Ford Family Trust DTD June 2, 2014."
FAQ
What stock option exercises did ABT Chairman and CEO Robert B. Ford report?
Robert B. Ford exercised employee stock options for 398,832 ABT common shares on 2026-08-25, including 151,869 shares at an exercise price of $44.40 and 246,963 shares at an exercise price of $59.94, converting them into common shares.
Which Abbott incentive plans were the exercised ABT options granted under?
The 151,869-share option (exercise price $44.40) was granted under the Abbott Laboratories 2009 Incentive Stock Program, and the 246,963-share option (exercise price $59.94) was granted under the Abbott Laboratories 2017 Incentive Stock Program, both in transactions exempt under Rule 16b-3.
Were the ABT transactions reported under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked, and the footnotes do not state that these transactions were made pursuant to a Rule 10b5-1 trading plan or other pre-arranged trading arrangement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
